Filtered By:
Vaccination: Vaccines
Countries: Iran Health
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 756 results found since Jan 2013.
COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran
CONCLUSION: The rates of contracting COVID-19 after vaccination were relatively high. SARS-CoV-2 Vaccine (Vero Cell) provided lower protection against COVID-19 than other vaccines. People with comorbidities had higher risks of contracting COVID-19 and hospitalization and should be prioritized for preventive interventions.PMID:35923277 | PMC:PMC9306382 | DOI:10.2471/BLT.22.288073
Source: Bulletin of the World Health Organization - August 4, 2022 Category: International Medicine & Public Health Authors: Ali Hosseinzadeh Sajad Sahab-Negah Sairan Nili Roqayeh Aliyari Shahrbanoo Goli Mohammad Fereidouni Ali Alami Mohsen Shati Elham Ahmadnezhad Shiva Mehravaran Mansooreh Fateh Hamidreza Khajeha Zahra Emamian Elahe Behmanesh Sepideh Mahdavi Mostafa Enayatrad Source Type: research
Influenza Vaccine Booster Stimulates Antibody Response in Beta Thalassemia Major Patients
Lab Med. 2022 Jul 18:lmac035. doi: 10.1093/labmed/lmac035. Online ahead of print.ABSTRACTThe aim of this study was to evaluate antibody response against influenza vaccine in beta thalassemia major patients from Iran. Thirty beta thalassemia major patients were enrolled and divided into three groups: single dose (group 1), double dose (group 2), and control (group 3). Seroconversion, seroprotection, and geometric mean titer (GMT) assays were performed through hemagglutination inhibition (HI) on days 0, 14, and 60. Based on the results, the level of antibody titer was increased in group 2. Two weeks after vaccination, seroco...
Source: Cancer Control - July 18, 2022 Category: Cancer & Oncology Authors: Maryam Sheikh Abbas Ahmadi-Vasmehjani Mohammad Reza Atashzar Mohammad Hadi Karbalaie Niya Arefeh Ebrahimian Rasoul Baharlou Source Type: research
The effect of COVID 19 vaccination on kidney recipients
CONCLUSION: Even after vaccination, kidney recipients are still at the risk of contracting SARS-CoV-2. In addition to these results, the efficacy of vaccination in preventing death caused by SARS-CoV-2 was confirmed.PMID:35777613 | PMC:PMC9238056 | DOI:10.1016/j.trim.2022.101658
Source: Transplant Immunology - July 1, 2022 Category: Transplant Surgery Authors: Latifi Marzieh Pourhosein Elahe Rahban Habib Pourhosein Maryam Jafarian Arefeh Eskandarzadeh Elnaz Dehghani Sanaz Source Type: research
COVID-19 vaccine-related frequently asked questions (FAQs) by people with epilepsy and carers in Iran; educational video is included
CONCLUSION: Our findings may be used by policy-makers to prepare appropriate educational materials to provide the best targeted and tailored information to people with epilepsy and their carers to convince them of the necessity and safety of COVID-19 vaccination. Such an educational material must include enough information on the associated adverse effects of COVID-19 vaccines and should also discuss some other important issues such as indications of these vaccines in special populations and drug-vaccine interactions.PMID:35696935 | PMC:PMC9117255 | DOI:10.1016/j.yebeh.2022.108763
Source: Epilepsy and Behaviour - June 13, 2022 Category: Neurology Authors: Ali A Asadi-Pooya Afrooz Karimi Seyed Mohammad Ali Razavizadegan Nahid Ashjazadeh Hamid Nemati Source Type: research
Decrescent role of recombinant HSP60 antibody against atherosclerosis in high-cholesterol diet immunized rabbits
CONCLUSION: Taking recombinant protein concomitant with a fatty diet, causes betterment of atherosclerosis via decreasing aggregation of cholesterol and thickness of the endothelial media.PMID:35656453 | PMC:PMC9118271 | DOI:10.22038/IJBMS.2021.56382.12580
Source: Atherosclerosis - June 3, 2022 Category: Cardiology Authors: Saghar Zonnar Said Abdul Ghafour Saeedy Fahimeh Nemati Mohammad Javad Motamedi Hamidreza Raeespour Jafar Amani Source Type: research
